Next generation sequencing for targeted personalized Therapy of Leukemia

10 international partners are joining their efforts to build up a highly innovative and ambitious research project: the outstanding mission of sequencing the genome of Leukemia patients to develop personalized and more effective therapies.

The NGS-PTL Project

The NGS-PTL project aims at developing a European platform of scientists for improving outcomes for therapeutic interventions on acute and chronic leukemias and at developing strategies to personalize treatments and tailor therapies to different groups of leukemia patients.
The NGS-TPTL Project
news list
Publications
publications list

Partners

Alma Mater Studiorum - Università di Bologna | Università degli Studi di Torino | Personal Genomics Srl | Sinaptica IT Srl | Universitaet Ulm | KU Leuven | Fasteris SA | Masarykova Univerzita | Fundacion de Investigacion del Cancer de la Universidad de Salamanca | MLL Muenchner Leukaemie laboratory GmbH